Stay up to date with the latest news about our innovation initiatives

Published on 08/02/2024

Seeking new therapies through AI

Almirall, Barcelona Supercomputing Center (BSC) and Nostrum Biodiscovery collaborate to design new protein-protein modulators through Artificial Intelligence.

We are looking for collaboration opportunites focused on pathological mechanisms common across different organs and tissues that can be translatable to skin diseases

Published on 25/05/2023

New models for non-melanoma skin cancer

Almirall and the Centre for Genomic Regulation (CRG) collaborate to develop and characterize novel preclinical models for non-melanoma skin cancer

Published on 28/11/2022

Almirall joins IMI project FACILITATE

We participate in FACILITATE, a patient-driven Innovative Medicines Initiative (IMI) project to enable the use of clinical trial data by study participants.